期刊文献+

大剂量丙种球蛋白治疗扩张型心肌病心力衰竭患者的效果 被引量:1

Efficacy of high-dose gamma globulin in patients with heart failure due to dilated cardiomyopathy
下载PDF
导出
摘要 目的评价大剂量丙种球蛋白治疗对扩张型心肌病心力衰竭患者的效果。方法选择我院收治的96例扩张型心肌病心衰患者,按照1∶1比例分为观察组和对照组,各48例。对照组接受常规治疗,观察组接受常规治疗+大剂量丙种球蛋白治疗。对比两组治疗效果。结果治疗后,两组LVEDD、LVEF、BNP、IgG水平较治疗前均改善,观察组优于对照组(P<0.05)。观察组患者好转率为83.33%,明显高于对照组的50.00%(P<0.05)。两组患者不良反应发生率比较,差异无统计学意义(P>0.05)。结论常规治疗基础上配合大量丙种球蛋白治疗扩张型心肌病心衰可以提高治疗效果,改善患者的LVEDD、LVEF、BNP及Ig G水平。 Objective To evaluate the effect of high-dose gamma globulin in patients with heart failure due to dilated cardiomyopathy.Methods A total of 96 patients with heart failure due to dilated cardiomyopathy admitted in our hospital were divided into observation group and control group according to the ratio of 1:1,with 48 cases in each group.The control group received routine therapy,and the observation group received conventional therapy plus high-dose gamma globulin therapy.The therapeutic effects between the two groups were compared.Results After treatment,the levels of LVEDD,LVEF,BNP and IgG in both groups improved compared with those before treatment,and those in the observation group were better than the control group(P<0.05).The improvement rate of the observation group was 83.33%,which was significantly higher than 50.00%of the control group(P<0.05).There was no significant difference in the incidence rate of adverse reactions between the two groups(P跃0.05).Conclusion High-dose gamma globulin applied in patients with heart failure due to dilated cardiomyopathy on the basis of routine treatment can improve the effect of treatment,and improve the levels of LVEDD,LVEF BNP,and IgG of the patients.
作者 牟涌 MU Yong(Hanzhong Central Hospital,Hanzhong 723000,China)
出处 《临床医学研究与实践》 2018年第10期15-16,共2页 Clinical Research and Practice
关键词 大剂量丙种球蛋白 扩张型心肌病 心力衰竭 high-dose gamma globulin dilated cardiomyopathy heart failure
  • 相关文献

参考文献6

二级参考文献25

  • 1李洪稳,周继新,尚爱英,王海英,王玉刚,元柏民.心脏介入术后并发急性肺血栓栓塞的预防和护理[J].中国实用护理杂志(中旬版),2006,22(3):23-23. 被引量:21
  • 2王轶智,沈云,高蕾.β受体阻滞剂治疗慢性重症充血性心力衰竭的护理体会[J].现代中西医结合杂志,2006,15(22):3127-3128. 被引量:18
  • 3Staudt A, Staudt Y, Dorr M, et al. Potential of humoralimmunity in cardiac dysfunction of patients sufferingfrom dilated cardiomyopathy [J]. J AM Coll Cardiol,2004,44(5):829-836.
  • 4Vou Haehling S,Doehner W, Auker SD. The roles of im-munity and autoimmunity in chronic heart failure [J].Ernst Schering Res Found Workshop, 2006 ,55 (1): 155-168.
  • 5Caforio AL, Daliento L,Angelini A, et al. Autoimmunemyocarditis and dilated cardiomyopathy focus on cardiacautoantibodies[J]. Lupus,2005,14(9) :652-655.
  • 6Rose NR,Beisel KW,Herskowitz A,et al. Cardiac myosinand autoimmune myocarditis[J]. Ciba Found Symp, 1987 ,129(1):3-24.
  • 7Liao LI,Sindhwani R,Rojkind M,et al. Antibody-mediat-ed autoimmune myocarditis depends on genetically deter-mined target organ sensitivity[J]. J Exp Med,1995,181(6)=1123-1131.
  • 8Huber SA. Auto immunity in myocarditis : relevance ofanimalmodels[J]. J Clin Immunol Immunopathol,1997,83(1):93-102.
  • 9Staudt A,Bohm M,Knebel F,et al. Potentiarole of autoantibodies be-longing to the immunoglobulinG — 3 subclass in cardiac dysfunction a-mong patientswith dilated cardiomyopathy [ J]. Circulation,2002,106(10):2448-2453.
  • 10Maisch B, Hufnagel G,Susanne K,et al. Treatment of in-flammatory dilatedcar-diomyopathy and (Peri) myocarditiswith immunosuppressionand i. v. immunoglobul-ins [J].Herz,2004,29(6) :624-636.

共引文献19

同被引文献23

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部